HDAC9 and scleroderma: With respect to dermal fibrosis, it was shown that the class I/II HDAC inhibitor, Trichostatin A, suppresses TGF-β-induced collagen up-regulation in scleroderma fibroblasts by interfering with Smad signaling [34].